These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3144689)

  • 21. A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain.
    Sweis D; Wong IC
    Drug Saf; 2000 Aug; 23(2):165-72. PubMed ID: 10945377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a videotape on adverse drug reactions.
    Morgan SA; Frank JT
    Am J Hosp Pharm; 1990 Jun; 47(6):1340-2. PubMed ID: 1695062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse drug reactions: the San Juan Department of Veterans Affairs Medical Center experience.
    Nazario M; Feliú JF; Rivera GC
    Hosp Pharm; 1994 Mar; 29(3):244-6, 249-50. PubMed ID: 10171808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
    Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
    Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A team approach to adverse drug reaction surveillance: success at a tertiary care hospital.
    Saltiel E; Johnson E; Shane R
    Hosp Formul; 1995 Apr; 30(4):226-8, 231-2. PubMed ID: 10141866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a hospital-based adverse drug reaction reporting program.
    Cantú TG; Tyler LS
    Hosp Formul; 1988 Aug; 23(8):658-61. PubMed ID: 10288394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reporting of adverse drug and biologic reactions in Mississippi hospitals.
    Fincham JE; Brown TR; Garner DD
    Hosp Pharm; 1988 Mar; 23(3):248-51. PubMed ID: 10286840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of a pharmacist-driven pharmacovigilance system in a secondary hospital in the Gauteng Province of South Africa.
    Terblanche A; Meyer JC; Godman B; Summers RS
    Hosp Pract (1995); 2018 Oct; 46(4):221-228. PubMed ID: 30092683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality improvement in the use of medications through a drug use evaluation service.
    Stevenson JG; Bakst CM; Zaran FK; Rybak MJ; Smolarek RT; Alexander MR
    Top Hosp Pharm Manage; 1992 Oct; 12(3):47-56. PubMed ID: 10128747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Program for improving adverse drug reaction reporting.
    Chatas CA; Vinson BE
    Am J Hosp Pharm; 1990 Jan; 47(1):155-7. PubMed ID: 2301425
    [No Abstract]   [Full Text] [Related]  

  • 31. An adverse drug reaction reporting system as an integral part of a drug-usage evaluation program.
    Saltiel E; Shane R
    Top Hosp Pharm Manage; 1991 Jul; 11(2):51-8. PubMed ID: 10128635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multidisciplinary program for detecting and evaluating adverse drug reactions.
    Keith MR; Bellanger-McCleery RA; Fuchs JE
    Am J Hosp Pharm; 1989 Sep; 46(9):1809-12. PubMed ID: 2801715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using the discharge process as one method to capture adverse drug reaction reports.
    Gee MA; Daniels BW
    Top Hosp Pharm Manage; 1992 Jul; 12(2):75-81. PubMed ID: 10128731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Program coordinated by a drug information service to improve adverse drug reaction reporting in a hospital.
    Michel DJ; Knodel LC
    Am J Hosp Pharm; 1986 Sep; 43(9):2202-5. PubMed ID: 3766573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia.
    Aldryhim AY; Alomair A; Alqhtani M; Mahmoud MA; Alshammari TM; Pont LG; Kamal KM; Aljadhey H; Mekonnen AB; Alwhaibi M; Balkhi B; Alhawassi TM
    Expert Opin Drug Saf; 2019 Aug; 18(8):745-752. PubMed ID: 31232612
    [No Abstract]   [Full Text] [Related]  

  • 36. Using a computerized discharge summary data base check box for adverse drug reaction monitoring.
    Schiff GD
    QRB Qual Rev Bull; 1990 Apr; 16(4):149-55. PubMed ID: 2113667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality assurance through adverse drug reaction reporting: improving hypnotic prescribing.
    Phillips MS
    Hosp Pharm; 1990 Mar; 25(3):246-8. PubMed ID: 10170509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Revised ADR report permits internal review of drug experience.
    Jeffrey LP
    Pharm Times; 1986 Dec; 52(12):48-50. PubMed ID: 10317827
    [No Abstract]   [Full Text] [Related]  

  • 39. Review of Canadian pharmacist involvement in adverse drug reaction reporting.
    Taras-Zasowski KM; Einarson TR
    Can J Hosp Pharm; 1989 Jun; 42(3):105-8, 133. PubMed ID: 10318271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of adverse drug reactions detected by pharmacy and medical records departments.
    Johnstone DM; Kirking DM; Vinson BE
    Am J Health Syst Pharm; 1995 Feb; 52(3):297-301. PubMed ID: 7749958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.